Health Care

Healthcare Stocks in Spotlight: Johnson & Johnson (NYSE:JNJ) , Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

0 7

Johnson & Johnson (NYSE:JNJ) initiated the shares trading at $119.37 and showed negative change of -0.12% while the stock’s final trade was registered at $ 119.47. However, its previous closing price was seen at $119.61. The stock negotiated total number of 4.83 million shares as compared to 3 months average volume of 6.65 million shares.

The stock price demonstrated downbeat change from its 50 day moving average of 121.99 and had been up from its 200 Day Moving Average of 115.28.

Brokerage Recommendations:

The stock has received ratings from many brokerage firms according to ZACKS. Currently shares have been rated as “Buy” from “2” brokerage firms and “7” brokerage firms say as “Strong Buy”. “0” brokerage firms have suggested “Sell” for the company. “8” brokerage firms have recommended as a “Hold”. Strong Sell rating was given by “1” brokerage firms.  The Company has average brokerage recommendation (ABR) of “2.22” based on consensus of the ZACKS brokerage firms.

The average true range of Johnson & Johnson’s (JNJ) is recorded at 0.92 and the relative strength index of the stock stands 42.30. The stock price is going above to its 52 week low with 36.71% and lagging behind from its 52 week high with -4.60%. Analyst recommendation for this stock stands at 2.40. A look on the firm performance, its monthly performance is -2.56% and a quarterly performance of 2.79%. The stock price is trading upbeat from its 200 days moving average with 8.90% and down from 50 days moving average with -1.74%.

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) climbed +0.67% and ended at $28.65 greater than previous closing price of $28.46. The total 1.26 million shares were bought and sold throughout the most recent trading session less than average volume of 2.58 million shares.

Brokerage Recommendations:

The stock has received ratings from many brokerage firms according to ZACKS. Currently shares have been rated as “Buy” from “1” brokerage firms and “3” brokerage firms say as “Strong Buy”. “1” brokerage firms have suggested “Sell” for the company. “5” brokerage firms have recommended as a “Hold”. Strong Sell rating was given by “3” brokerage firms.  The Company has average brokerage recommendation (ABR) of “3” based on consensus of the ZACKS brokerage firms.

Sarepta Therapeutics, Inc.’s (SRPT) has price-to-cash ratio of 11.00 and price to sale ratio of 1042.64. . A look on the firm performance, its monthly performance is 7.95% and a quarterly performance of 36.49%. The stock price is moving up from its 20 days moving average with 9.63% and isolated positively from 50 days moving average with 18.63%.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter